Refine
Has Fulltext
- yes (181)
Is part of the Bibliography
- yes (181)
Year of publication
Document Type
- Journal article (173)
- Doctoral Thesis (8)
Language
- English (181) (remove)
Keywords
- COVID-19 (12)
- blood-brain barrier (11)
- inflammation (10)
- endothelial cells (8)
- molecular docking (8)
- blood–brain barrier (7)
- cytokines (6)
- sepsis (6)
- microRNA (5)
- stroke (5)
- tight junctions (5)
- Medizin (4)
- SARS-CoV-2 (4)
- breast cancer (4)
- critical illness (4)
- expression (4)
- in vitro (4)
- neuropathic pain (4)
- pain (4)
- Gibbs free energy of binding (3)
- acute kidney injury (3)
- acute respiratory distress syndrome (3)
- astrocytes (3)
- blood brain barrier (3)
- central nervous system (3)
- critical care (3)
- gene expression (3)
- ischemia (3)
- macrophages (3)
- molecular dynamics (3)
- oxygen/glucose deprivation (3)
- patient blood management (3)
- skeletal muscle (3)
- systematic review (3)
- traumatic brain injury (3)
- Alzheimer’s disease (2)
- Blut-Hirn-Schranke (2)
- CNS disorders (2)
- CRPS (2)
- Germany (2)
- Malignant hyperthermia (2)
- Schlaganfall (2)
- Schmerzforschung (2)
- Succinylcholine (2)
- age-related hearing loss (2)
- aging (2)
- anaemia (2)
- analysis of variance (2)
- anesthetics (2)
- animal model (2)
- antimicrobial stewardship (2)
- barrier (2)
- blood (2)
- blood gas analysis (2)
- blood nerve barrier (2)
- blood-nerve barrier (2)
- blood–labyrinth barrier (2)
- brain (2)
- cEND (2)
- capsaicin (2)
- cerebEND (2)
- chemokines (2)
- chronic pain (2)
- claudin-1 (2)
- clinical trial (2)
- critically ill (2)
- cytotoxicity (2)
- endotoxemia (2)
- evaluation (2)
- exosomes (2)
- glioma (2)
- glucocorticoid receptor (2)
- glucocorticoids (2)
- heart failure (2)
- intensive care (2)
- iron deficiency (2)
- ischemia-reperfusion injury (2)
- lessons learned (2)
- malignant hyperthermia (2)
- mass casualties (2)
- medical nutrition therapy (2)
- meta-analysis (2)
- mice (2)
- multidrug resistance (2)
- neuropathy (2)
- neurotrophins (2)
- oxidative stress (2)
- perioperative care (2)
- postoperative nausea and vomiting (2)
- pregnancy (2)
- randomized controlled trial (2)
- rat (2)
- rolipram (2)
- safety (2)
- simulation (2)
- spiral ganglion neuron (2)
- terror attack (2)
- vitamin C (2)
- vitamin D (2)
- volatile anesthetics (2)
- zinc (2)
- (cardiac) surgery (1)
- 3D in vitro model (1)
- 4D (1)
- 6-percent hydroxyethyl starch (1)
- AD pathogenesis (1)
- APC (1)
- ARDS (1)
- ARDS (acute respiratory distress syndrome) (1)
- ATP-binding cassette transporter (1)
- Accelerometry (1)
- Afferent nerve stimulation (1)
- Alzheimer's disease (1)
- Analgesia (1)
- Anästhesiologie (1)
- Apoptosis (1)
- Apple Watch 7 (1)
- Articular afferent (1)
- Aspartate Aminotransferases (1)
- Axl tyrosine kinase (1)
- Axonschaden (1)
- BDNF (1)
- BIRC7 (1)
- BK channel (1)
- BV-2 (1)
- Bland–Altman (1)
- Blood–brain barrier (1)
- C6 (1)
- CASP (1)
- CNS diseases (1)
- CNS injury (1)
- COVID 19 (1)
- COVID-19 pandemic (1)
- COVID‐19 (1)
- CT (1)
- CX3CL1 (1)
- CXCL13 (1)
- CXCR4-targeting (1)
- Ca2+ homeostasis (1)
- Ca2+ ion analysis (1)
- Ca2+ leak (1)
- Ca2+ oscillation (1)
- Capsaicin (1)
- Central venous-pressure (1)
- Claudin (1)
- ClearSight\(^®\) (1)
- Colloids (1)
- Complex regional pain syndrome (1)
- Computertomographie (1)
- Coronavirus Disease 2019 (1)
- Covid-19 (1)
- Creatine Kinase (1)
- Critically-ill patients (1)
- Crystalloids (1)
- Cutaneous hyperemia (1)
- DAMGO (1)
- DRG (1)
- Disaster response (1)
- Dorsal Root Ganglion (1)
- ER Ca2+ imaging (1)
- ER Ca2+ store (1)
- Einfluss (1)
- Elective cesarean-section (1)
- Electrical impedance tomography (1)
- Emery-Dreifuss muscular dystrophy (1)
- Endogenous opioids (1)
- Entzündung (1)
- Epidural Analgesia (1)
- Evaluation (1)
- Exercise testing (1)
- Expression (1)
- Extracorporeal Membrane Oxygenation (1)
- Fisher Z-score transformation (1)
- Fitbit Sense (1)
- Fresh Freeze Plasma (1)
- GABA\(_A\) (1)
- GBM (1)
- GDNF (1)
- GRO alpha (1)
- Garmin Fenix 6 Pro (1)
- Gene expression vectors (1)
- General anaesthesia (1)
- Glucosetransportproteine (1)
- HCW (1)
- HER2 conversion (1)
- HER2 targeted therapy (1)
- HER2-low (1)
- HES (1)
- HIV (1)
- HPβCD (1)
- Halothane (1)
- Hamman's syndrome (1)
- Healthcare Cost (1)
- Healthcare Economics (1)
- High-Frequency Ventilation (1)
- Horowitz Quotient (1)
- Hospital emergency plan (1)
- Hypertonic saline 7.5-percent (1)
- ICU staff (1)
- ICU treatment (1)
- IL-6 (1)
- IL6 (1)
- IMA2.1 (1)
- INR rebound (1)
- ISS (1)
- In Situ Nick-End Labeling (1)
- In vitro contracture test (1)
- In vitro models (1)
- Inferior Vena Cava (1)
- Inflammation (1)
- Inflammatory Pain (1)
- Inflammatory pain (1)
- Interactive Ventilatory Support (1)
- Ionenkanal (1)
- Joint pain (1)
- Komplexes regionales Schmerzsyndrom (1)
- L-Lactate Dehydrogenase (1)
- Labour Analgesia (1)
- Labour Pain (1)
- Lactated ringers solution (1)
- Lamarckian genetic algorithms (1)
- Latrophilin (1)
- Lessons Learnt (1)
- Longitudinal analysis (1)
- Lung Injury (1)
- MK801 (1)
- MMP9 (1)
- Macrophage Migration Inhibitory Factor (MIF) (1)
- Major abdominal surgery (1)
- Mass critical care (1)
- Medical Managment (1)
- Metastatic breast cancer (1)
- Microcirculation (1)
- NF-kappa-B (1)
- NMDA-Antagonist (1)
- NMDA-Rezeptor (1)
- NMDAR (1)
- NS1608 (1)
- NSAIDs (1)
- NaV1.8 (1)
- Neuralgie (1)
- Neurogenie inflammation (1)
- Neuropathic Pain (1)
- Neuropathic pain (1)
- Neuropathischer Schmerz (1)
- Neuropathy (1)
- Neutrophils (1)
- New Zealand (1)
- Nicardipine (1)
- Nitric oxide (NO) (1)
- Nociceptor (1)
- North American (1)
- OSC (1)
- Oxidized Phospholipids (1)
- Oxygen uptake (1)
- P-glycoprotein (1)
- P-gp inhibitors (1)
- PBM (1)
- PCDHGC3 (1)
- PDE4-inhibitor roflumilast (1)
- PIK3R1 (1)
- POLO-chart (1)
- POLSCORE (1)
- Pain (1)
- Patient Blood Management (PBM) (1)
- Patient Controlled Analgesia (1)
- Patient Satisfaction (1)
- Pearson correlation coefficient (1)
- Phase II trials (1)
- Phospholipide (1)
- Polymerase chain reaction (1)
- Positive-Pressure Respiration (1)
- Postoperative complications (1)
- Predict fluid responsiveness (1)
- Prognose (1)
- Pulmonary Embolism (1)
- Pulmonary function tests (1)
- Puls-pressure variation (1)
- QST (1)
- Quantitative sensory testing (1)
- Questionnaire (1)
- RECK (1)
- Randomized controlled-trial (1)
- Remifentanil (1)
- RyR1 mutations (1)
- SERCA (1)
- SIRS (1)
- SOFA Score (1)
- SWCNT CNTs (1)
- Sanger sequencing (1)
- Schmerztherapie (1)
- Sepsis (1)
- Serotonin (5-HT) (1)
- Severe Acute Respiratory Syndrome Coronavirus 2 (1)
- Shotgun method (1)
- Simulation (1)
- Spumaviren (1)
- Surgery (1)
- Swine (1)
- Synthetic biology (1)
- TNF-α (1)
- TRP channel (1)
- TRPA1 (1)
- TRPA1 channel (1)
- TTFields (1)
- TTS (1)
- Takotsubo cardiomyopathy (1)
- Takotsubo syndrome (1)
- Terror (1)
- Tight Junction Proteins (1)
- Tjap1 (1)
- Toll like receptors (1)
- Transwell® system (1)
- Tumor-Treating Fields (TTFields) (1)
- Tyrian purple (1)
- University Hospital (1)
- VACV (1)
- Venous Thrombosis (1)
- Virtual sequencing (1)
- Volatile anesthetics (1)
- WNT signaling (1)
- Withings ScanWatch (1)
- Wnt signaling (1)
- ZO-1 (1)
- Zika virus (1)
- \(^1\)H-NMR spectroscopy (1)
- activated-receptor gamma (1)
- activity-dependent slowing (1)
- acupuncture (1)
- acute Respiratory Distress Syndrome (1)
- acute liver failure (1)
- acute lung injury (1)
- acute respiratory distress syndrome (ARDS) (1)
- adhesion molecules (1)
- adrenal tumor (1)
- adrenocortical cancer (1)
- adsorption (1)
- aged 80 and over (1)
- aggregation (1)
- agnoists (1)
- airway management (1)
- alveolar epithelium in vitro model, claudin-1, claudin-3, claudin-4, claudin-5 (1)
- alzheimer's disease (1)
- amyloid cardiomyopathy (1)
- anaemia walk‐in clinic (1)
- anaesthesiology (1)
- anaesthetics (1)
- analgesia (1)
- analgesics (1)
- anesthesia (1)
- anesthesiologists (1)
- anesthesiology (1)
- aneurysm repair (1)
- aneurysmal subarachnoid haemorrhage (1)
- angiogenesis (1)
- angioplasty (1)
- animals (1)
- anthocyanin derivatives (1)
- anti-cancer drug-like molecules (1)
- anti-hormonal therapy (1)
- antibacterial activity (1)
- antibiotic prescribing quality (1)
- anticoagulant therapy (1)
- anticoagulation (1)
- antiemetics (1)
- antioxidant (1)
- antithrombotic therapy (1)
- anxiety (1)
- apolipoprotein J (1)
- apoptosis (1)
- approved drugs (1)
- arteriovenous extracorporeal hemadsorption technique (1)
- artificial intelligence (1)
- astrocytoma (1)
- atrial fibrillation (1)
- automated external defibrillators (1)
- autonomic nervous system (1)
- avoidable blood loss (1)
- awake prone positioning (1)
- axonal damage (1)
- barrier properties (1)
- bibliometrics (1)
- bioactive peptide (1)
- bioelectronics (1)
- bleeding (1)
- blood loss (1)
- blood purification (1)
- blood transfusion (1)
- blood–brain barrier choline transporter (1)
- brain pathology (1)
- brain-metastasis (1)
- breast cancer metastases (1)
- bridging (1)
- c-fos (1)
- caffeine (1)
- calcitonin gene-related peptide (1)
- calcium level (1)
- calorimetry (1)
- cancer (1)
- carbon nanoparticles (1)
- carcinogen activation (1)
- cardiac arrest documentation (1)
- cardiac protection (1)
- cardiac surgery (1)
- cardio-pulmonary resuscitation (1)
- cardioprotection (1)
- cardiopulmonary resuscitation (1)
- caspase-3 (1)
- cell stretch (1)
- cell-adhesion (1)
- central autonomic network (1)
- central core disease (1)
- cerebEND cells (1)
- cerebral ischemia (1)
- cerebrovascular disorders (1)
- chemical similarity (1)
- chest-compression rate (1)
- children (1)
- chronic constriction injury (1)
- chronic musculoskeletal pain (1)
- claudin-12 (1)
- claudin-5 (1)
- clinical decision support (1)
- clinical measurement in health technology (1)
- clinical studies (1)
- clinical trials (1)
- clusterin transporter (1)
- colloids (1)
- colorectal carcinoma (1)
- comparative molecular field analysis (1)
- comparative molecular similarity index analysis (1)
- comparison (1)
- complex regional pain syndrome (1)
- complications (1)
- conference abstracts (1)
- connective tissue (1)
- coronary artery bypass (1)
- coronavirus disease 2019 (1)
- corticosteroids (1)
- costs (1)
- creatinine (1)
- cyclodextrin (1)
- cyclodextrin formulations (1)
- cytochrome P450 3A4 (1)
- cytokine expression (1)
- data display (1)
- death (1)
- demography (1)
- density functional theory (1)
- depression (1)
- dexamethasone (1)
- diabetes mellitus (1)
- diabetic nephropathy (1)
- diabetic retinopathy (1)
- diagnostic blood loss (1)
- diagnostic correctness (1)
- diazepam (1)
- differentially expressed genes (1)
- diffusion (1)
- digital phenotyping (1)
- disease (1)
- dorsal root ganglion (1)
- drug delivery (1)
- drug delivery vector (1)
- drug repurposing (1)
- drug transporter (1)
- drug-drug interactions (1)
- dual-room trauma suite (1)
- dual-room whole-body CT (1)
- dysfunction (1)
- ecological momentary assessment (1)
- electrical excitability (1)
- electrical impedance tomography (1)
- emergency (1)
- emergency information (1)
- emergency preparedness (1)
- encephalitis dementia (1)
- endocarditis (1)
- endothelial injury (1)
- endotoxin (1)
- enhanced recovery after surgery (1)
- enzyme-linkes immunoassays (1)
- epidural anaesthesia (1)
- epidural analgesia (1)
- epidural anesthesia (1)
- estrogens (1)
- ether (1)
- etomidate (1)
- eudaimonia (1)
- evidence synthesis (1)
- exercise (1)
- exposure (1)
- extracellular vesicles (1)
- extracorporeal hemadsorption (1)
- extracorporeal membrane oxygenation (ECMO) (1)
- extracorporeal techniques in hemadsorption therapy (1)
- extravascular lung water (1)
- failure (1)
- fascia (1)
- fears (1)
- fentanyl (1)
- fermentation (1)
- fetal lung (1)
- first responders (1)
- fish oil (1)
- fitness trackers (1)
- fluorescein isothiocyanate (1)
- fluorescence microscopy (1)
- formulations (1)
- frailty (1)
- free energy (1)
- free energy of solvation (1)
- free flap surgery (1)
- fullerenes (1)
- gastrointestinal tract (1)
- gene ontology (1)
- general anaesthesia (1)
- general anesthesia (1)
- genetic polymorphisms (1)
- genotoxicity (1)
- giant ventral hernia (1)
- glioblastoma multiforme (1)
- glut1 (1)
- good clinical practice (1)
- gradient optimisation (1)
- graft surgery (1)
- growth differentiation factor 15 (1)
- guideline adherence (1)
- guideline usage (1)
- haemoglobin concentration (1)
- haemostasis (1)
- halothane (1)
- health care payers (1)
- health care workers (1)
- health sciences (1)
- health tracker (1)
- health-care workers (1)
- healthcare (1)
- heart (1)
- hedonia (1)
- hemadsorption (1)
- high-flow nasal cannula (1)
- histopathology (1)
- human (1)
- human brain microvascular endothelial cells (HBMVEC) (1)
- human cells (1)
- human immunodeficiency virus (1)
- humans (1)
- hydrochloride (1)
- hyperalgesia (1)
- hypertonic solution (1)
- hypoxia (1)
- iatrogenic anemia (1)
- immortalization (1)
- immune response (1)
- immunology (1)
- immunonutrition (1)
- immunosorbents (1)
- immunostaining (1)
- impedance aggregometry; WHOLE-BLOOD THROMBOELASTOMETRY; DEFINITION; DISEASE (1)
- implementation (1)
- in vitro cell culture models (1)
- in vitro contracture test (1)
- in vitro model (1)
- in-bed cycling (1)
- in-hospital cardiac arrest (1)
- indigo (1)
- induced impairment (1)
- infiltration (1)
- inflammatory bowel disease (1)
- inflammatory cytokines (1)
- inflammatory pain (1)
- inflammatory response (1)
- infodemic (1)
- information strategies (1)
- inhalation anesthetics (1)
- inhibition (1)
- inner ear (1)
- innovative surgical methods (1)
- inos (1)
- insular cortex (1)
- intensive care medicine (1)
- intensive care unit (1)
- internalization (1)
- internet of things (1)
- intestinal absorption (1)
- intestinal microvascular perfusion (1)
- intracerebral haemorrhage (1)
- involvement (1)
- ion channel (1)
- ion channels in the nervous system (1)
- ischemia/reperfusion injury (1)
- isosteviol sodium (1)
- isosteviol sodium (STVNA) (1)
- kidney (1)
- kidney ischemia/reperfusion injury (1)
- kidneys (1)
- laparoscopic surgery (1)
- laparostomy (1)
- laterality (1)
- left-ventricular assist device (1)
- levosimendan (1)
- lidocaine (1)
- lipids (1)
- livin (1)
- lnterleukin-lβ (1)
- longitudinal studies (1)
- low molecular heparin (1)
- low-risk intra-abdominal infections (1)
- lung injury (1)
- mRNA (1)
- machine learning (1)
- macrophage migration inhibitory factor (MIF) (1)
- major bleeding (1)
- management (1)
- maternal critical care (1)
- mean force potential (1)
- meaning (1)
- mechanical ventilation (1)
- mechanical ventilator weaning (1)
- mechanisms (1)
- medical devices (1)
- medicine (1)
- metabolizing rate (1)
- metastasis (1)
- miRNS (1)
- mices (1)
- microanastomosis (1)
- microarray (1)
- microdialysis (1)
- microglia (1)
- micronutrients (1)
- microparticles (1)
- microvascular complications (1)
- microvascular endothelial cells (1)
- midazolam (1)
- milk proteins (1)
- mimetic peptide (1)
- minimally invasive surgery (1)
- mission strategies (1)
- mitochondria (1)
- mobile crowdsensing (1)
- mobile health (1)
- moderate sedation (1)
- molecular imaging (1)
- molecular liphophilicity potential (1)
- molecular medicine (1)
- molecular modeling (1)
- molecular modelling (1)
- monocytes (1)
- mortality (1)
- mouse models (1)
- movable sliding gantry (1)
- multidisciplinary (1)
- multimodal treatments (1)
- multiwalled carbon nanotube (1)
- muscle (1)
- muscle disease (1)
- myelin barrier (1)
- myeloperoxidase (1)
- myocardial infarction (1)
- myocardial-infarction (1)
- myotonia congenita (1)
- nanomedicine (1)
- necrosis factor alpha (1)
- need satisfaction (1)
- nerve (1)
- nerve injury (1)
- nervous system (1)
- netrin-1 (1)
- network meta-analysis (1)
- neurological complications (1)
- neurology (1)
- neuronal tracing (1)
- neuroprotection (1)
- neuropsychiatric disorders (1)
- neuroscience (1)
- neurotrophic factor (1)
- neurovascular disorders (1)
- neurovasculature (1)
- neutrophil (1)
- nitric oxide (1)
- no-flow fraction (1)
- nociception (1)
- non-invasive ventilation (1)
- nutrient supplementation (1)
- nutrition (1)
- nutrition therapy (1)
- obstetrics (1)
- omega-3 fatty acid (1)
- omega-6 fatty acid (1)
- one‐lung ventilation (1)
- open abdomen (1)
- opioid peptides (1)
- opioid receptors (1)
- opioids (1)
- oral anticoagulants (1)
- oral nutrition supplements (1)
- orthopaedic patients (1)
- oxidised lipids (1)
- oxidized phospholipids (1)
- oxygen-glucose deprivation (1)
- pain behavior (1)
- pain therapy (1)
- pandemia (1)
- parenteral nutrition (1)
- pathophysiology (1)
- patient (1)
- patient serum (1)
- paxilline (1)
- peptide synthesis (1)
- performance (1)
- perioperative antibiotic prophylaxis (1)
- peripheral nerve (1)
- peripheral nerve injury (1)
- permeability (1)
- personalized antimicrobial therapy (1)
- personalized medicine (1)
- pharmaceutical applications (1)
- pharmacokinetic delivery (1)
- pharmacokinetics (1)
- pharmacology (1)
- pharmacotherapy (1)
- phenprocoumon (1)
- phosphatidylinositol (1)
- phosphodiesterase (1)
- photoplethysmography (1)
- physical activity (1)
- pi-pi stacking (1)
- pigs (1)
- pioglitazone (1)
- piperacillin/tazobactam (1)
- point of care testing (1)
- point-of-care (1)
- point-of-care-testing (1)
- polarization (1)
- polymers (1)
- population characteristics (1)
- post-traumatic stress disorder (1)
- postoperative bleeding (1)
- postoperative complications (1)
- preconditioning (1)
- prehabilitation (1)
- preoperative anaemia management (1)
- presynaptic inhibition (1)
- preterm birth (1)
- prevalence (1)
- primary endpoint (1)
- primary microvascular endothelial cells (1)
- primary outcome (1)
- prognostic marker (1)
- proliferation (1)
- propofol (1)
- propranolol (1)
- prospective studies (1)
- protein (1)
- protein corona (1)
- protein expression (1)
- protein hydrolysis (1)
- protein-protein interaction network (1)
- proteins (1)
- protocadherin gamma C3 (1)
- public health preparedness (1)
- pulmonary edema (1)
- pulmonary function tests (1)
- pulmonary surgical procedures (1)
- punctate mechanical allodynia (1)
- qualitative research (1)
- quality assurance (1)
- quality indicators (1)
- quantum mechanics (1)
- questionnaire (1)
- rational drug design (1)
- reactive oxygen species (1)
- receptor antagonist (1)
- receptors (1)
- recombinant DNA (1)
- recurrence (1)
- red blood cell transfusion (1)
- red blood cells (1)
- relapse (1)
- reperfusion injury (1)
- repetitive firing (1)
- rescue mission (1)
- research integrity (1)
- resolvin (1)
- respiratory distress syndrome (1)
- respiratory failure (1)
- resuscitation time (1)
- reticulocyte haemoglobin (1)
- risk prediction (1)
- robotic surgery (1)
- ryanodine receptor gene (1)
- sarcoplasmic reticulum (1)
- scaffold search (1)
- scanning electron microscopy (1)
- sciatic nerve (1)
- scurvy (1)
- selective outcome reporting (1)
- selen (1)
- selenium (1)
- senescence (1)
- sensory neurons (1)
- septic shock (1)
- severe multiple trauma (1)
- sevoflurane (1)
- sex hormone (1)
- sglt1 (1)
- shape-based approach (1)
- sheep (1)
- side-effects (1)
- single-electron transistor (1)
- single-walled carbon nanotubes (1)
- situation awareness (1)
- situational awareness (1)
- smartwatch (1)
- smooth muscle cells (1)
- solnatide (1)
- spinal dorsal horn (1)
- spontaneous pneumomediastinum (1)
- spontaneous pneumopericardium (1)
- sport medicine (1)
- stent (1)
- store-operated Ca2+ entry (1)
- stress (1)
- stress resilience (1)
- structure-activity relationship (1)
- subarachnoid hemorrhage (1)
- succinylcholine (1)
- supine hypotensive syndrome (1)
- surgery (1)
- survey (1)
- susceptibility (1)
- suxamethonium (1)
- synthetic mesh (1)
- systematic review, (1)
- systemic inflammatory response syndrome (1)
- systemic reviews (1)
- targeting (1)
- team-training (1)
- technology (1)
- terror attacks (1)
- theranostics (1)
- therapeutic antibody (1)
- therapeutic drug monitoring (1)
- therapy (1)
- three-dimensional quantitative structure–activity relationship (1)
- thromboelastometry (1)
- thromboembolism (1)
- thrombosis (1)
- tight junction (1)
- tight junction protein (1)
- tight junction proteins (1)
- torsional energy (1)
- trace elements (1)
- transfusion (1)
- transient receptor potential channels (1)
- transition state (1)
- transport inhibition assay (1)
- transporter (1)
- trastuzumab (1)
- trastuzumab deruxtecan (1)
- trauma centre (1)
- trauma management (1)
- trial protocol (1)
- trial registration (1)
- trimethyl-β-cyclodextrin (1)
- tumor (1)
- tumor microenvironment (1)
- tumor necrosis factor-α (1)
- ulfobutylether-\(\beta\)-cyclodextrin (1)
- ultrasound strain elastography (1)
- ultrastructure (1)
- urgent surgery (1)
- urine (1)
- user experience (1)
- user-centred design (1)
- vaccination (1)
- vaccination campaign (1)
- vaccination hesitancy (1)
- vaccine (1)
- vaccine hesitancy (1)
- vaccine refusal (1)
- vacuum conditioning (1)
- video laryngoscopy (1)
- viral load (1)
- virtual reality (1)
- virtual screening (1)
- viruses (1)
- vitamins (1)
- vitro contracture test (1)
- volume clamp (1)
- vomiting (1)
- warfarin interruption (1)
- water (1)
- wearable (1)
- white blood cells (1)
- wistar rats (1)
- µ-Opioid receptor (1)
Institute
- Klinik und Poliklinik für Anästhesiologie (ab 2004) (181) (remove)
Sonstige beteiligte Institutionen
- Zentrallabor, Universitätsklinikum Würzburg (2)
- Apotheke, Universitätsklinikum Würzburg (1)
- Department of Medicinal Chemistry, University of Vienna, Althanstraße 14, 1090 Vienna, Austria (1)
- Department of Pharmaceutical Technology and Biopharmaceutics, University of Vienna, Althanstraße 14, 1090 Vienna, Austria (1)
- EMBL Mouse Biology Unit, Monterotondo, Italien (1)
- Interdisziplinäres Zentrum für Klinische Forschung (ZIKF), Würzburg (1)
- Klinik und Poliklinik für Anästhesiologie, Intensivmedizin, Notfallmedizin und Schmerztherapie des Universitätsklinikums Würzburg (1)
- Krankenhaushygiene und Antimicrobial Stewardship (1)
- Krankenhaushygiene und Antimicrobial Stewardship, Universitätsklinikum Würzburg (1)
In 1747, an important milestone in the history of clinical research was set, as the Scottish surgeon James Lind conducted the first randomized controlled trial. Lind was interested in scurvy, a severe vitamin C deficiency which caused the death of thousands of British seamen. He found that a dietary intervention with oranges and lemons, which are rich in vitamin C by nature, was effective to recover from scurvy. Because of its antioxidative properties and involvement in many biochemical processes, the essential micronutrient vitamin C plays a key role in the human biology. Moreover, the use of vitamin C in critical illness—a condition also resulting in death of thousands in the 21st century—has gained increasing interest, as it may restore vascular responsiveness to vasoactive agents, ameliorate microcirculatory blood flow, preserve endothelial barriers, augment bacterial defense, and prevent apoptosis. Because of its redox potential and powerful antioxidant capacity, vitamin C represents an inexpensive and safe antioxidant, with the potential to modify the inflammatory cascade and improve clinical outcomes of critically ill patients. This narrative review aims to update and provide an overview on the role of vitamin C in the human biology and in critically ill patients, and to summarize current evidence on the use of vitamin C in diverse populations of critically ill patients, in specific focusing on patients with sepsis and coronavirus disease 2019.
Evidence synthesis findings depend on the assumption that the included studies follow good clinical practice and results are not fabricated or false. Studies which are problematic due to scientific misconduct, poor research practice, or honest error may distort evidence synthesis findings. Authors of evidence synthesis need transparent mechanisms to identify and manage problematic studies to avoid misleading findings. As evidence synthesis authors of the Cochrane COVID-19 review on ivermectin, we identified many problematic studies in terms of research integrity and regulatory compliance. Through iterative discussion, we developed a research integrity assessment (RIA) tool for randomized controlled trials for the update of this Cochrane review. In this paper, we explain the rationale and application of the RIA tool in this case study. RIA assesses six study criteria: study retraction, prospective trial registration, adequate ethics approval, author group, plausibility of methods (e.g., randomization), and plausibility of study results. RIA was used in the Cochrane review as part of the eligibility check during screening of potentially eligible studies. Problematic studies were excluded and studies with open questions were held in awaiting classification until clarified. RIA decisions were made independently by two authors and reported transparently. Using the RIA tool resulted in the exclusion of >40% of studies in the first update of the review. RIA is a complementary tool prior to assessing “Risk of Bias” aiming to establish the integrity and authenticity of studies. RIA provides a platform for urgent development of a standard approach to identifying and managing problematic studies.
Inflammation and oxidative stress represent physiological response mechanisms to different types of stimuli and injury during critical illness. Its proper regulation is fundamental to cellular and organismal survival and are paramount to outcomes and recovery from critical illness. A proper maintenance of the delicate balance between inflammation, oxidative stress, and immune response is crucial for resolution from critical illness with important implications for patient outcome. The extent of inflammation and oxidative stress under normal conditions is limited by the antioxidant defense system of the human body, whereas the antioxidant capacity is commonly significantly compromised, and serum levels of micronutrients and vitamins significantly depleted in patients who are critically ill. Hence, the provision of antioxidants and anti-inflammatory nutrients may help to reduce the extent of oxidative stress and therefore improve clinical outcomes in patients who are critically ill. As existing evidence of the beneficial effects of antioxidant supplementation in patients who are critically ill is still unclear, actual findings about the most promising anti-inflammatory and antioxidative candidates selenium, vitamin C, zinc, and vitamin D will be discussed in this narrative review. The existing evidence provided so far demonstrates that several factors need to be considered to determine the efficacy of an antioxidant supplementation strategy in patients who are critically ill and indicates the need for adequately designed multicenter prospective randomized control trials to evaluate the clinical significance of different types and doses of micronutrients and vitamins in selected groups of patients with different types of critical illness.
In a recent study, we showed in an in vitro murine cerebellar microvascular endothelial cell (cerebEND) model as well as in vivo in rats that Tumor-Treating Fields (TTFields) reversibly open the blood–brain barrier (BBB). This process is facilitated by delocalizing tight junction proteins such as claudin-5 from the membrane to the cytoplasm. In investigating the possibility that the same effects could be observed in human-derived cells, a 3D co-culture model of the BBB was established consisting of primary microvascular brain endothelial cells (HBMVEC) and immortalized pericytes, both of human origin. The TTFields at a frequency of 100 kHz administered for 72 h increased the permeability of our human-derived BBB model. The integrity of the BBB had already recovered 48 h post-TTFields, which is earlier than that observed in cerebEND. The data presented herein validate the previously observed effects of TTFields in murine models. Moreover, due to the fact that human cell-based in vitro models more closely resemble patient-derived entities, our findings are highly relevant for pre-clinical studies.
Purpose
Therapeutic options for breast cancer (BC) treatment are constantly evolving. The Human Epidermal Growth Factor 2 (HER2)-low BC entity is a new subgroup, representing about 55% of all BC patients. New antibody–drug conjugates demonstrated promising results for this BC subgroup. Currently, there is limited information about the conversion of HER2 subtypes between primary tumor and recurrent disease.
Methods
This retrospective study included women with BC at the University Medical Centre Wuerzburg from 1998 to 2021. Data were retrieved from patients' records. HER2 evolution from primary diagnosis to the first relapse and the development of secondary metastases was investigated.
Results
In the HR-positive subgroup without HER2 overexpression, HER2-low expression in primary BC was 56.7 vs. 14.6% in the triple-negative subgroup (p < 0.000). In the cohort of the first relapse, HER2-low represented 64.1% of HR-positive vs. 48.2% of the triple-negative cohort (p = 0.03). In patients with secondary metastases, HER2-low was 75.6% vs. 50% in the triple negative subgroup (p = 0.10). The subgroup of HER2-positive breast cancer patients numerically increased in the course of disease; the HER2-negative overall cohort decreased. A loss of HER2 expression from primary BC to the first relapse correlated with a better OS (p = 0.018). No clinicopathological or therapeutic features could be identified as potential risk factors for HER2 conversion.
Conclusion
HER2 expression is rising during the progression of BC disease. In view of upcoming therapeutical options, the re-analysis of newly developed metastasis will become increasingly important.
Effect of Tjap1 knock-down on blood-brain barrier properties under normal and hypoxic conditions
(2023)
Stroke is one of the leading causes of mortality and disability worldwide. The blood-brain barrier (BBB) plays an important role in maintaining brain homeostasis by tightly regulating the exchange of substances between circulating blood and brain parenchyma. BBB disruption is a common pathologic feature of stroke and traumatic brain injury. Understanding the cellular and molecular events that affect the BBB after ischaemic brain injury is important to improve patient prognosis.
We have previously shown that microRNA-212/132 is elevated in hypoxic brain microvascular endothelial cells and acts through suppressing the expression of direct microRNA-212/132 target genes with function at the BBB: claudin-1, junctional adhesion molecule 3 (Jam3) and tight-junction associated protein 1 (Tjap1). While the role of claudin-1 and Jam3 at the BBB is well known, the role of Tjap1 is still unclear. The aim of this work was therefore to characterize the role of Tjap1 in brain endothelial cells using a knock-down (KD) approach in established murine in vitro BBB models cEND and cerebEND. Tjap1 KD was established by stable transfection of a plasmid expressing shRNA against Tjap1. The successful downregulation of Tjap1 mRNA and protein was demonstrated by qPCR and Western blot. Tjap1 KD resulted in impaired barrier properties of endothelial cells as shown by lower TEER values and higher paracellular permeability. Interestingly, the Tjap1 KD cells showed lower cell viability and proliferation but migrated faster in a wound healing assay. In the tube formation assay, Tjap1 KD cell lines showed a lower angiogenic potential due to a significantly lower tube length and number as well as a lower amount of branching points in formed capillaries. Tjap1 KD cells showed changes in gene and protein expression. The TJ proteins claudin-5, Jam3 and ZO-1 were significantly increased in Tjap1 KD cell lines, while occludin was strongly decreased. In addition, efflux pump P-glycoprotein was downregulated in Tjap1 KD cells. Oxygen-glucose deprivation (OGD) is a method to mimic stroke in vitro. Brain endothelial cell lines treated with OGD showed lower barrier properties compared to cells cultured under normal condition. These effects were more severe in Tjap1 KD cells, indicating active Tjap1 involvement in the OGD response in brain microvascular endothelial cells.
We thus have shown that Tjap1 contributes to a tight barrier of the BBB, regulates cell viability and proliferation of endothelial cells, suppresses their migration and promotes new vessel formation. This means that Tjap1 function is important for mature BBB structure in health and disease.
Artificial intelligence (AI) is predicted to play an increasingly important role in perioperative medicine in the very near future. However, little is known about what anesthesiologists know and think about AI in this context. This is important because the successful introduction of new technologies depends on the understanding and cooperation of end users. We sought to investigate how much anesthesiologists know about AI and what they think about the introduction of AI-based technologies into the clinical setting. In order to better understand what anesthesiologists think of AI, we recruited 21 anesthesiologists from 2 university hospitals for face-to-face structured interviews. The interview transcripts were subdivided sentence-by-sentence into discrete statements, and statements were then grouped into key themes. Subsequently, a survey of closed questions based on these themes was sent to 70 anesthesiologists from 3 university hospitals for rating. In the interviews, the base level of knowledge of AI was good at 86 of 90 statements (96%), although awareness of the potential applications of AI in anesthesia was poor at only 7 of 42 statements (17%). Regarding the implementation of AI in anesthesia, statements were split roughly evenly between pros (46 of 105, 44%) and cons (59 of 105, 56%). Interviewees considered that AI could usefully be used in diverse tasks such as risk stratification, the prediction of vital sign changes, or as a treatment guide. The validity of these themes was probed in a follow-up survey of 70 anesthesiologists with a response rate of 70%, which confirmed an overall positive view of AI in this group. Anesthesiologists hold a range of opinions, both positive and negative, regarding the application of AI in their field of work. Survey-based studies do not always uncover the full breadth of nuance of opinion amongst clinicians. Engagement with specific concerns, both technical and ethical, will prove important as this technology moves from research to the clinic.
Visual Blood, a 3D animated computer model to optimize the interpretation of blood gas analysis
(2023)
Acid–base homeostasis is crucial for all physiological processes in the body and is evaluated using arterial blood gas (ABG) analysis. Screens or printouts of ABG results require the interpretation of many textual elements and numbers, which may delay intuitive comprehension. To optimise the presentation of the results for the specific strengths of human perception, we developed Visual Blood, an animated virtual model of ABG results. In this study, we compared its performance with a conventional result printout. Seventy physicians from three European university hospitals participated in a computer-based simulation study. Initially, after an educational video, we tested the participants’ ability to assign individual Visual Blood visualisations to their corresponding ABG parameters. As the primary outcome, we tested caregivers’ ability to correctly diagnose simulated clinical ABG scenarios with Visual Blood or conventional ABG printouts. For user feedback, participants rated their agreement with statements at the end of the study. Physicians correctly assigned 90% of the individual Visual Blood visualisations. Regarding the primary outcome, the participants made the correct diagnosis 86% of the time when using Visual Blood, compared to 68% when using the conventional ABG printout. A mixed logistic regression model showed an odds ratio for correct diagnosis of 3.4 (95%CI 2.00–5.79, p < 0.001) and an odds ratio for perceived diagnostic confidence of 1.88 (95%CI 1.67–2.11, p < 0.001) in favour of Visual Blood. A linear mixed model showed a coefficient for perceived workload of −3.2 (95%CI −3.77 to −2.64) in favour of Visual Blood. Fifty-one of seventy (73%) participants agreed or strongly agreed that Visual Blood was easy to use, and fifty-five of seventy (79%) agreed that it was fun to use. In conclusion, Visual Blood improved physicians’ ability to diagnose ABG results. It also increased perceived diagnostic confidence and reduced perceived workload. This study adds to the growing body of research showing that decision-support tools developed around human cognitive abilities can streamline caregivers’ decision-making and may improve patient care.
Interpreting blood gas analysis results can be challenging for the clinician, especially in stressful situations under time pressure. To foster fast and correct interpretation of blood gas results, we developed Visual Blood. This computer-based, multicentre, noninferiority study compared Visual Blood and conventional arterial blood gas (ABG) printouts. We presented six scenarios to anaesthesiologists, once with Visual Blood and once with the conventional ABG printout. The primary outcome was ABG parameter perception. The secondary outcomes included correct clinical diagnoses, perceived diagnostic confidence, and perceived workload. To analyse the results, we used mixed models and matched odds ratios. Analysing 300 within-subject cases, we showed noninferiority of Visual Blood compared to ABG printouts concerning the rate of correctly perceived ABG parameters (rate ratio, 0.96; 95% CI, 0.92–1.00; p = 0.06). Additionally, the study revealed two times higher odds of making the correct clinical diagnosis using Visual Blood (OR, 2.16; 95% CI, 1.42–3.29; p < 0.001) than using ABG printouts. There was no or, respectively, weak evidence for a difference in diagnostic confidence (OR, 0.84; 95% CI, 0.58–1.21; p = 0.34) and perceived workload (Coefficient, 2.44; 95% CI, −0.09–4.98; p = 0.06). This study showed that participants did not perceive the ABG parameters better, but using Visual Blood resulted in more correct clinical diagnoses than using conventional ABG printouts. This suggests that Visual Blood allows for a higher level of situation awareness beyond individual parameters’ perception. However, the study also highlighted the limitations of today’s virtual reality headsets and Visual Blood.
Propofol is a widely used general anesthetic in clinical practice, but its use is limited by its water-insoluble nature and associated pharmacokinetic and pharmacodynamic limitations. Therefore, researchers have been searching for alternative formulations to lipid emulsion to address the remaining side effects. In this study, novel formulations for propofol and its sodium salt Na-propofolat were designed and tested using the amphiphilic cyclodextrin (CD) derivative hydroxypropyl-β-cyclodextrin (HPβCD). The study found that spectroscopic and calorimetric measurements suggested complex formation between propofol/Na-propofolate and HPβCD, which was confirmed by the absence of an evaporation peak and different glass transition temperatures. Moreover, the formulated compounds showed no cytotoxicity and genotoxicity compared to the reference. The molecular modeling simulations based on molecular docking predicted a higher affinity for propofol/HPβCD than for Na-propofolate/HPβCD, as the former complex was more stable. This finding was further confirmed by high-performance liquid chromatography. In conclusion, the CD-based formulations of propofol and its sodium salt may be a promising option and a plausible alternative to conventional lipid emulsions.